Zoledronic Acid

Zoledronic Acid Injection is indicated for treatment of Paget’s disease of bone in men and women. Treatment is indicated in patients with Paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease

For indications, dosing and other information, please refer to the prescribing information.

Zoledronic Acid ‐ Sagent

5 mg, 100 mL
NDC #: